Next, CRC cells were treated with the PI3K/AKT inhibitor LY294002 to determine whether the ability of ECM1 to mediate EMT induction is tied to PI3K/AKT/GSK3β/Snail signaling pathway activation. Here, ECM1 is linked to colorectal carcinoma.